US2006025852A1PendingUtilityA1

Bioabsorbable self-expanding endolumenal devices

45
Assignee: ARMSTRONG JOSEPH RPriority: Aug 2, 2004Filed: Aug 2, 2004Published: Feb 2, 2006
Est. expiryAug 2, 2024(expired)· nominal 20-yr term from priority
A61F 2/01A61F 2002/91508A61F 2250/003A61F 2/915A61F 2230/005A61B 17/12118A61F 2220/0016A61F 2002/91525A61F 2230/008A61F 2002/91533A61L 31/148A61B 2017/1205A61F 2002/30062A61B 17/1214A61F 2230/0069A61B 17/12022A61L 31/06A61F 2210/0004A61F 2210/0076A61F 2002/016A61F 2/91A61F 2002/9155A61F 2002/018A61F 2230/0054
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention is directed to bioabsorbable self-expanding medical devices for use inside or outside body conduits that self-expand at, or below, normal human body temperature without requisite for a polymeric thermal transition

Claims

exact text as granted — not AI-modified
1 . An implantable medical device comprising: 
 an integral framework delimiting a multiplicity of fenestrations, said framework comprising a non-blended hydrolyzable polymeric material; and    wherein said framework is substantially tubular in shape and radially expands from a compressed first diameter to an uncompressed second diameter equal to or greater than 1.5 times said first diameter within two minutes following application and release of a compressive force while immersed in an aqueous medium at 37 degrees centigrade without requisite for an extrinsically applied force and without requisite for a thermal transition.    
   
   
       2 . The implantable medical device of  claim 1  wherein said Integral framework does not change axial length significantly as said integral framework expands radially.  
   
   
       3 . The implantable medical device of  claim 1  wherein the device is a stent.  
   
   
       4 . The implantable medical device of  claim 1  wherein said integral framework has elements with different cross-sectional dimensions.  
   
   
       5 . The implantable medical device of  claim 1  wherein said integral framework has elements comprising bioabsorbable material having different chemical compositions.  
   
   
       6 . The implantable medical device of  claim 2  wherein the stent has a fenestration pattern substantially as shown in  FIG. 1 .  
   
   
       7 . The implantable medical device of  claim 1  wherein the non-blended hydrolyzable polymeric material is a tri-block co-polymer of poly(glycolide) and poly(trimethylenecarbonate).  
   
   
       8 - 36 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.